Form 4: Tango Therapeutics CEO Barbara Weber Reports Acquisition of Restricted Stock Units and Stock Options
SEC Form 4 Filing
CEO Barbara Weber reports the acquisition of restricted stock units and stock options in Tango Therapeutics, Inc.
Summary
- Barbara Weber, CEO of Tango Therapeutics, reported the acquisition of 105,875 restricted stock units (RSUs) and 635,250 stock options on February 3, 2025.
- The RSUs vest over a three-year period, with 33% vesting on February 2, 2026, 33% on February 1, 2027, and 34% on February 14, 2028.
- The stock options vest over a four-year period, with 25% vesting on January 1, 2026, and the remaining shares vesting in 36 equal monthly installments thereafter.
- Following these transactions, Weber directly owns 1,641,042 shares of Tango Therapeutics common stock and 635,250 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing. The acquisition of shares by the CEO could be interpreted slightly positively, but it's primarily an informational document.
Positives
- The acquisition of RSUs and stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in the biotechnology industry.
Stakeholder Impact
- The acquisition of shares by the CEO may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of transaction: Acquisition of RSUs and stock options. |
| 02/03/2025 | Stock options granted. |
| 01/01/2026 | 25% of stock options vest. |
| 02/02/2026 | 33% of RSUs vest. |
| 02/01/2027 | 33% of RSUs vest. |
| 02/14/2028 | 34% of RSUs vest. |
| 02/03/2035 | Expiration date of stock options. |
| 02/05/2025 | Date of Form 4 filing. |
Keywords
Tango Therapeutics, Barbara Weber, CEO, Form 4, RSU, Stock Options, Beneficial Ownership, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.